Health Canada Approves Methyl Aminolevulinate Cream for Use With Red Light Technology
Unregistered User
If this is not your name, click here.
Contact Us | Order Now | Journals | Bookstore | Register a colleague
 
  SEARCH  
News
Bookstore
Medline
The Web
Meetings & Congresses
Complete Doctor's Guide
 


 EXPLORE :
 news  All News
 webcasts All Webcasts
 All cases All Cases
 Meetings All Meetings & Congresses
 Medical All Medical Resources

top





New drugs / indications

English Dictionary

Medical Dictionary

Thesaurus



Warning | Privacy | Awards



 Favourite Journals 

Click here to choose your favourite journals


 Favourite Sites 

Click here to choose your favourite sites


 Languages 



  




Health Canada Approves Methyl Aminolevulinate Cream for Use With Red Light Technology

NEW YORK -- April 21, 2009 -- Health Canada has approved an LED-based narrow band (630 nm) red light technology device (Aktilite CL128) in combination with methyl aminolevulinate (Metvix) for the treatment of actinic keratosis (AK) and superficial basal cell carcinoma (sBCC).

The approval is based on data from multiple studies in which 211 patients with multiple AKs in face or scalp were treated with the methyl aminolevulinate cream or placebo prior to illumination with Aktilite. Both studies showed significantly better response with the cream compared with placebo at 3 months after treatment.

The approval for the sBCC indication is based on a study which included 196 patients treated with either methyl aminolevulinate or excision surgery. Three months after treatment the reduction in lesion count was nearly 90% and similar for the 2 treatments. One year after treatment the cosmetic outcome was significantly better for the patients treated with methyl aminolevulinate compared with the patients who had surgical treatment.

SOURCE: Photocure ASA

E-mail this page
to a friend or colleague!
To print,
use this version




Any question regarding a medical diagnosis, treatment, referral, drug availability or pricing should be directed to either a licensed physician or to the product's manufacturer.

If you have any technical questions or other concerns about this site, feel free to contact us at webmaster@docguide.com.

All contents Copyright (c) 1995- Doctor's Guide Publishing Limited. All rights reserved.


Employment opportunities | Partnering opportunities